Literature DB >> 9883905

Construction of single-chain antibodies that bind an overlapping epitope of HIV-1 Nef.

A H Chang1, J A Hoxie, S Cassol, M O'Shaughnessy, F Jirik.   

Abstract

The light and heavy chain variable regions of three mouse hybridoma cell lines (AG11, AE6 and EH1) that produce monoclonal antibodies against an overlapping epitope at the C-terminus of Nef were cloned. Sequence analysis of the light and heavy chain variable regions indicated that clones AG11 and AE6, but not EH1, were highly related. Single-chain antibodies were constructed from the cDNA clones of AG11 and EH1, and subcloned into an eukaryotic expressing vector with the green fluorescent protein as marker for expression. Such intracellular antibodies may provide a way in which to inhibit the function of Nef during HIV-1 infection of cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9883905     DOI: 10.1016/s0014-5793(98)01569-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Intracellular Nef detected in peripheral blood mononuclear cells from HIV patients.

Authors:  Ting Wang; Linden A Green; Samir K Gupta; Tohti Amet; Daniel J Byrd; Qigui Yu; Homer L Twigg; Matthias Clauss
Journal:  AIDS Res Hum Retroviruses       Date:  2014-09-04       Impact factor: 2.205

2.  Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.

Authors:  Ming Li; Jason M Aliotta; John M Asara; Lynne Tucker; Peter Quesenberry; Michelle Lally; Bharat Ramratnam
Journal:  Proteomics       Date:  2012-07       Impact factor: 3.984

3.  ADP ribosylation factor 1 activity is required to recruit AP-1 to the major histocompatibility complex class I (MHC-I) cytoplasmic tail and disrupt MHC-I trafficking in HIV-1-infected primary T cells.

Authors:  Elizabeth R Wonderlich; Jolie A Leonard; Deanna A Kulpa; Kay E Leopold; Jason M Norman; Kathleen L Collins
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

4.  Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications.

Authors:  Biswajit Das; Curtis Dobrowolski; Abdel-Malek Shahir; Zhimin Feng; Xiaolan Yu; Jinfeng Sha; Nabil F Bissada; Aaron Weinberg; Jonathan Karn; Fengchun Ye
Journal:  Virology       Date:  2014-11-14       Impact factor: 3.616

5.  Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta.

Authors:  Veronique Stove; Inge Van de Walle; Evelien Naessens; Elisabeth Coene; Christophe Stove; Jean Plum; Bruno Verhasselt
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Self-association of the Lentivirus protein, Nef.

Authors:  Youn Tae Kwak; Alexa Raney; Lillian S Kuo; Sarah J Denial; Brenda R S Temple; J Victor Garcia; John L Foster
Journal:  Retrovirology       Date:  2010-09-23       Impact factor: 4.602

7.  HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail.

Authors:  Jeremiah F Roeth; Maya Williams; Matthew R Kasper; Tracey M Filzen; Kathleen L Collins
Journal:  J Cell Biol       Date:  2004-11-29       Impact factor: 10.539

8.  In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis.

Authors:  Richard L Watkins; Wei Zou; Paul W Denton; John F Krisko; John L Foster; J Victor Garcia
Journal:  Retrovirology       Date:  2013-10-30       Impact factor: 4.602

9.  Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir.

Authors:  Biswajit Das; Curtis Dobrowolski; Benjamin Luttge; Saba Valadkhan; Nicolas Chomont; Rowena Johnston; Peter Bacchetti; Rebecca Hoh; Monica Gandhi; Steven G Deeks; Eileen Scully; Jonathan Karn
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

10.  HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells.

Authors:  Malinda R Schaefer; Elizabeth R Wonderlich; Jeremiah F Roeth; Jolie A Leonard; Kathleen L Collins
Journal:  PLoS Pathog       Date:  2008-08-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.